ORBIMED ADVISORS LLC purchased 1.46M shares of KINNATE BIOPHARMA INC. on the open market
Open‑market purchase worth $4.09M. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 5/8/2023ACC: 0000947871-23-000541
Director10% Owner
Since Dec 2020
+1.46M
Net shares
Net buyer
$4.09M
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
1.46M acquired
Non-Derivative Transactions5
Common Stock
Indirect
Shares
+83.46K
Price / share
$2.75
Trade value
$229.51K
% of position
10.5%
5/4/2023
794.37K→877.83K
Common Stock
Indirect
Shares
+312.99K
Price / share
$2.75
Trade value
$860.73K
% of position
7.1%
5/4/2023
4.43M→4.74M
Common Stock
Indirect
Shares
+83.46K
Price / share
$2.75
Trade value
$229.51K
% of position
10.5%
5/4/2023
794.37K→877.83K
Common Stock
Indirect
Shares
+490.51K
Price / share
$2.82
Trade value
$1.38M
% of position
55.9%
5/5/2023
877.83K→1.37M
Common Stock
Indirect
Shares
+490.51K
Price / share
$2.82
Trade value
$1.38M
% of position
55.9%
5/5/2023
877.83K→1.37M
Total
Net shares
+1.46M
Net value
$4.09M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/4/2023 | P · Purchase | +83.46K | $2.75 | $229.51K | 10.5% | 794.37K | 877.83K |
| Common Stock Indirect | 5/4/2023 | P · Purchase | +312.99K | $2.75 | $860.73K | 7.1% | 4.43M | 4.74M |
| Common Stock Indirect | 5/4/2023 | P · Purchase | +83.46K | $2.75 | $229.51K | 10.5% | 794.37K | 877.83K |
| Common Stock Indirect | 5/5/2023 | P · Purchase | +490.51K | $2.82 | $1.38M | 55.9% | 877.83K | 1.37M |
| Common Stock Indirect | 5/5/2023 | P · Purchase | +490.51K | $2.82 | $1.38M | 55.9% | 877.83K | 1.37M |
| Total | +1.46M | $4.09M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned84.60K
Common Stock
IndirectShares owned450K
Total
534.60K indirect534.60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 84.60K | Indirect |
| Common Stock | 450K | Indirect |
| Total | 534.60K | 534.60K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported